and Human Services (HHS)
EXPIRED
Participating Organization(s) |
National Institutes of Health (NIH) |
National Institute on Aging (NIA) |
|
Funding Opportunity Title |
Grants for Early Medical/Surgical Specialists Transition to Aging Research (R03) |
Activity Code |
R03 Small Grant Program |
Announcement Type |
Reissue of RFA-AG-11-007 |
Related Notices |
|
Funding Opportunity Announcement (FOA) Number |
RFA-AG-12-002 |
Companion FOA |
None |
Catalog of Federal Domestic Assistance (CFDA) Number(s) |
93.866 |
FOA Purpose |
This program is intended for early career physicians trained in medical or surgical specialties to establish a research track record in aging-related aspects of their specialty. The award will provide an opportunity to gain skills and experience in aging research and help investigators establish an independent program of research in their clinical field relevant to geriatric or gerontologic science. More information about the GEMSSTAR program can be found on the NIA website at http://www.nia.nih.gov/ResearchInformation/ExtramuralPrograms/GeriatricsAndClinicalGerontology/ |
Posted Date |
June 30, 2011 |
Open Date (Earliest Submission Date) |
September 3, 2011 |
Letter of Intent Due Date |
September 3, 2011 |
Application Due Date(s) |
October 3, 2011, by 5:00 PM local time of applicant organization. |
AIDS Application Due Date(s) |
Not applicable |
Scientific Merit Review |
February/March, 2012 |
Advisory Council Review |
May, 2012 |
Earliest Start Date(s) |
July, 2012 |
Expiration Date |
October 4, 2011 |
Due Dates for E.O. 12372 |
Not Applicable |
Required Application Instructions
It is critical that applicants follow the instructions in the SF 424 (R&R) Application Guide except where instructed to do otherwise (in this FOA or in a Notice from the NIH Guide for Grants and Contracts). Conformance to all requirements (both in the Application Guide and the FOA) is required and strictly enforced. Applicants must read and follow all application instructions in the Application Guide as well as any program-specific instructions noted in Section IV. When the program-specific instructions deviate from those in the Application Guide, follow the program-specific instructions. Applications that do not comply with these instructions may be delayed or not accepted for review.
Part 1. Overview Information
Part 2. Full Text of the Announcement
Section I. Funding Opportunity Description
Section II. Award Information
Section III. Eligibility Information
Section IV. Application and Submission
Information
Section V. Application Review Information
Section VI. Award Administration Information
Section VII. Agency Contacts
Section VIII. Other Information
The National Institute on Aging (NIA) offers this initiative to promote research conducted by early stage physicians trained in medical or surgical specialties who are entering careers as clinician-scientists in aging-related aspects of their specialty.
The 2008 Institute of Medicine report Retooling for an Aging America: Building the Health Care Workforce (http://www.iom.edu/Reports/2008/Retooling-for-an-Aging-America-Building-the-Health-Care-Workforce.aspx) emphasized the emergent need for additional health care personnel to address the medical needs of a growing population of older Americans with complex medical problems. Effective approaches to this impending health care crisis involve not only increasing the number of practicing physicians trained in geriatrics and in specialty fields related to the health problems of elders, but also fostering the development of the next generation of physician-scientists whose clinical research will lead to improved care and more effective treatment options for older patients with complex medical conditions.
A pivotal point in the development of clinician-scientists is the completion of training in a medical or surgical specialty and the first faculty appointment. At this early stage, limited research experience and publication record preclude competitiveness for many kinds of advanced research opportunities. This transition stage may be particularly difficult for a specialty-trained physician focusing on aging-related aspects of his/her specialty, as multidisciplinary research entails training that is rarely available in conventional programs. Thus, mechanisms that allow these physicians to begin research projects and establish a research track record are a priority for cultivating the next generation of clinician-scientists, particularly at the interface of aging and medical/surgical specialties.
The goal of the Grants for Early Medical/Surgical Specialists Transition to Aging Research (GEMSSTAR) program is to promote future leaders in clinical aging research across the range of medical and surgical specialties. To accomplish this goal, NIA will provide two years of support for small research projects to physicians trained in medical or surgical specialties who seek to become clinician-scientists in aging-related aspects of their specialty. Eligible applicants include, but are not limited to, physicians in traditional medical or surgical specialties, anesthesiologists, emergency medicine physicians, family medicine practitioners, general internists, general surgeons, geriatricians, hospitalists, neurologists, obstetricians/gynecologists, palliative care physicians, physiatrists, and psychiatrists. As described below, research support through this initiative will be contingent on applicants demonstration of acceptable professional development activities and related support.
More information about the GEMSSTAR program can be found on the NIA website at http://www.nia.nih.gov/ResearchInformation/ExtramuralPrograms/GeriatricsAndClinicalGerontology/
The GEMSSTAR program is intended to support a specialist s first independent research project in aging. Applicants are generally expected to have received no prior research funding as principal investigators, though they may have support through institutional awards, such as career development awards (K12), a Clinical and Translational Science Award (KL2), or Older Americans Independence Center Research Career Development Awards (OAIC RCDC). In unusual circumstances where an applicant with funding support in a non-aging-related field wishes to refocus his/her research efforts on aging-related issues, there should be a strong and clear explanation in both the R03 proposal and in the subsequently submitted Professional Development Plan (if requested) for how the proposed research will entail a meaningful shift towards aging-related science within the applicant’s clinical specialty. Merely supplementing the applicant’s current research efforts with aging-related science would not be considered a meaningful shift.
Through this proposed initiative, physicians trained in medical and surgical specialties who seek to bridge aging and clinical specialty disciplines can receive research project support through this NIH R03 mechanism. Research projects responsive to this initiative will combine aging with specialty clinical areas to focus on clinical or translational questions relevant to aging and/or the aged. The proposal should emphasize an integration of gerontologic or geriatric research with the candidate’s clinical specialty. Research may involve pilot or feasibility studies, secondary analysis of existing data, development of research methodology, or development of new research technology. Projects should be appropriate to the background and level of experience of the applicant. Potential research topics may include, but are not limited to:
R03 applicants must obtain additional support for a concurrent Professional Development Plan (PDP) to receive a GEMSSTAR award. The PDP should not be included in the R03 application; rather, candidates should submit PDPs to the NIH only after NIA staff have requested them following scientific peer review. Please see section IV.6. Other Submission Requirements for a complete description of the PDP requirement.
It is expected that applicants will have expertise in their clinical specialty, but may be less experienced in geriatric or gerontologic science or other areas. As such, applications should include at least one collaborator or consultant with complementary expertise in aging-related research and, if needed, in other areas appropriate to the proposed project. Such an individual could be, but not necessarily must be, a mentor named in the PDP.
Funding Instrument |
Grant |
Application Types Allowed |
New The OER Glossary and the SF 424 (R&R) Application Guide provide details on these application types. |
Funds Available and Anticipated Number of Awards |
NIA intends to commit $1.5 million in FY 2012 for approximately 18-20 awards. |
Award Budget |
Application budgets are limited to $50,000 in direct costs per year. |
Award Project Period |
Project period is limited to 2 years. |
NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made in response to this FOA.
Higher Education Institutions
The following types of Higher Education Institutions are always encouraged to apply for NIH support as Public or Private Institutions of Higher Education:
Nonprofits Other Than Institutions of Higher Education
For-Profit Organizations
Governments
Other
Non-domestic (non-U.S.) Entities (Foreign Institutions) are
not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Applicant organizations must complete the following registrations
as described in the SF 424 (R&R) Application Guide to be eligible to apply
for or receive an award. Applicants must have a valid Dun and Bradstreet
Universal Numbering System (DUNS) number in order to begin each of the following
registrations.
All Program Directors/Principal Investigators (PD/PIs) must
also work with their institutional officials to register with the eRA Commons
or ensure their existing eRA Commons account is affiliated with the eRA Commons
account of the applicant organization.
All registrations must be completed by the application due date. Applicant
organizations are strongly encouraged to start the registration process at
least four (4) weeks prior to the application due date.
Any individual(s) with the skills, knowledge, and resources
necessary to carry out the proposed research as the Program Director/Principal
Investigator (PD/PI) is invited to work with his/her organization to develop an
application for support. Individuals from underrepresented racial and ethnic
groups as well as individuals with disabilities are always encouraged to apply
for NIH support.
For institutions/organizations proposing multiple PDs/PIs, visit the Multiple
Program Director/Principal Investigator Policy and submission details in the Senior/Key
Person Profile (Expanded) Component of the SF 424 (R&R) Application Guide.
Awardees must be physicians (i.e., those with M.D., D.O., or equivalent degrees) who have completed training in their medical or surgical specialty. These specialties include, but are not limited to, the traditional medical and surgical specialties, anesthesiology, emergency medicine, family medicine, general internal medicine, general surgery, geriatrics, hospital medicine, neurology, obstetrics/gynecology, palliative medicine, physiatry/rehabiliation medicine, and psychiatry. This award is not intended for individuals with substantial experience in aging research. Moreover, it is generally expected that applicants will have not had prior research funding as Program Director/Principal Investigator (PD/PI), though they may have support through institutional awards, such as institutional career development awards (K12), Clinical and Translational Science Awards (KL2), or Older Americans Independence Center Research Career Development Awards (OAIC RCDC).
A candidate in their last year of specialty training is eligible to apply provided that the candidate’s institution has committed to appointing him/her to a faculty position no later than July 1, 2012. Faculty appointments that are contingent on receiving a GEMSSTAR award are not acceptable. Documentation of the institution’s commitment to make the faculty appointment must be included in the R03 application.
Except in unusual circumstances, it is expected that GEMSSTAR applications will have a single PD/PI, and that other personnel will be listed as collaborators or consultants. In multiple PD/PI applications, all principal investigators must be eligible for the GEMSSTAR program.
This FOA does not require cost sharing as defined in the NIH Grants Policy Statement.
Applicant organizations may submit more than one application, provided that each application is scientifically distinct.
NIH will not accept any application in response to this FOA that is essentially the same as one currently pending initial peer review unless the applicant withdraws the pending application. NIH will not accept any application that is essentially the same as one already reviewed. Resubmission applications may be submitted, according to the NIH Policy on Resubmission Applications from the SF 424 (R&R) Application Guide.
Applicants must download the SF424 (R&R) application package associated with this funding opportunity using the Apply for Grant Electronically button in this FOA or following the directions provided at Grants.gov.
It is critical that applicants follow the instructions in the SF424 (R&R) Application Guide, except where instructed in this funding opportunity announcement to do otherwise. Conformance to the requirements in the Application Guide is required and strictly enforced. Applications that are out of compliance with these instructions may be delayed or not accepted for review.
For information on Application Submission and Receipt, visit Frequently Asked Questions Application Guide, Electronic Submission of Grant Applications.
Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information that it contains allows IC staff to estimate the potential review workload and plan the review.
By the date listed in Part 1. Overview Information, prospective applicants are asked to submit a letter of intent that includes the following information:
The letter of intent should be sent to:
Ramesh Vemuri, Ph.D., Chief
Scientific Review Branch
National Institute on Aging
7201 Wisconsin Avenue, Room 2C212
Bethesda, MD 20892-9205 (Express Mail ZIP 20814)
Telephone: (301) 496-9666
FAX: (301) 402-0066
Email: [email protected]
The forms package associated with this FOA includes all applicable components, mandatory and optional. Please note that some components marked optional in the application package are required for submission of applications for this FOA. Follow all instructions in the SF424 (R&R) Application Guide to ensure you complete all appropriate optional components.
All page limitations described in the SF424 Application Guide and the Table of Page Limits must be followed.
PHS398 Modular Budget Component (direct costs of $250,000 or less):
Follow all instructions in the SF 424 (R&R) Application Guide
All instructions in the SF424 (R&R) Application Guide must be followed, with the following additional instructions:
Resource Sharing Plan
Individuals are required to comply with the instructions for the Resource Sharing Plans (Data Sharing Plan, Sharing Model Organisms, and Genome Wide Association Studies; GWAS) as provided in the SF424 (R&R) Application Guide.
Appendix
Do not use the appendix to circumvent page limits. Follow all instructions for the Appendix as described in the SF424 (R&R) Application Guide.
Part I. Overview Information contains information about Key Dates. Applicants are encouraged to submit in advance of the deadline to ensure they have time to make any application corrections that might be necessary for successful submission.
Organizations must submit applications via Grants.gov, the online portal to find and apply for grants across all Federal agencies. Applicants must then complete the submission process by tracking the status of the application in the eRA Commons, NIH’s electronic system for grants administration.
Applicants are responsible for viewing their application in the eRA Commons to ensure accurate and successful submission.
Information on the submission process and a definition of on-time submission are provided in the SF424 (R&R) Application Guide.
This initiative is not subject to intergovernmental review.
All NIH awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement.
Pre-award costs are allowable only as described in the NIH Grants Policy Statement.
Applications must be submitted electronically following the instructions described in the SF 424 (R&R) Application Guide. Paper applications will not be accepted.
Applicants must complete all required registrations before the application due date. Section III. Eligibility Information contains information about registration.
For assistance with your electronic application or for more information on the electronic submission process, visit Applying Electronically.
Important
reminders:
All PD/PIs must include their eRA Commons ID in the Credential
field of the Senior/Key Person Profile Component of the SF 424(R&R) Application
Package. Failure to register in the Commons and to include a valid PD/PI
Commons ID in the credential field will prevent the successful submission of an
electronic application to NIH.
The applicant organization must ensure that the DUNS number it provides on the
application is the same number used in the organization’s profile in the eRA
Commons and for the Central Contractor Registration (CCR). Additional
information may be found in the SF424 (R&R) Application Guide.
See more
tips for avoiding common errors.
Upon receipt, applications will be evaluated for completeness by the Center for Scientific Review and responsiveness by NIA, NIH. Applications that are incomplete and/or nonresponsive will not be reviewed.
Please see the NIA website for more information about the GEMSSTAR program at http://www.nia.nih.gov/ResearchInformation/ExtramuralPrograms/GeriatricsAndClinicalGerontology/
It is expected that applicants will have expertise in their clinical specialty, but may be less experienced in geriatric or gerontologic science. As such, applications should include at least one collaborator or consultant with complementary expertise in aging-related research and, if needed, in other areas appropriate to the proposed project. Such an individual could be, but not necessarily must be, a mentor named in the Professional Development Plan (PDP).
In accordance with the goals of the GEMSSTAR program, the Research Strategy and Biographical Sketches should emphasize how the candidate's proposed research will advance the understanding of aging-related science in the candidate’s specialty, as well as facilitate the candidate s transition specifically into aging research. If candidates have an established record of research, they must delineate in their Biographical Sketch how this project differs from their prior work and how the proposed project will assist them in focusing their research specifically on aging aspects of their specialty.
The personal statements of other investigators Biographical Sketches should describe how their expertise will complement that of the PD/PI to achieve the aims of the R03application.
It is not appropriate to discuss mentorship or the PDP in the R03 application. The R03 provides support only for activities related directly to research.
Applicants are required to follow the instructions for post-submission materials, as described in NOT-OD-10-115.
A PDP should not be submitted with the R03 application. A PDP should be submitted only after NIA staff have requested it following peer review. The following information is provided to applicants to help them plan ahead in the event that they are asked to submit a PDP.
Funding of this R03 award is contingent on having an NIA-approved PDP for the duration of the R03 award. The components of a PDP will differ for each applicant based on a variety of individual factors such as career stage, research experience, and institutional resources. The PDP should be tailored to meet the applicant’s individual professional development needs in relation to the R03 application. Moreover, the PDP should specifically describe activities that will augment the applicant’s skills in geriatrics and/or aging research to enable him/her to develop into an independent researcher in aging science. Although it is not possible to specify precisely what the parts of an individual PDP should be, inclusion of at least some of the following components is encouraged:
The above is not an exhaustive list; other appropriate activities not included above may be proposed.
In addition to a description of professional development activities, additional funding support should be obtained to provide protected time and resources to pursue the proposed professional development activities. Such support may be provided through a variety of sources, alone or in combination. These sources may include, but are not limited to, the following:
Acceptable and documented support for professional development activities must be in place prior to award of the R03 and must remain active during the entire R03 award period. The commitment of time and resources should be commensurate with activities outlined in the candidate's PDP. Professional Development Plans should include a description of the costs and level of professional effort associated with the proposed activities. Applicants for this initiative are advised to seek professional development support in the early stages of application. Acquiring support for professional development is the responsibility of the R03 applicant. Applicants are encouraged to share their R03 proposals and summary statements with all potential sources of PDP funding.
NIA staff will evaluate each PDP for the degree to which it supplements the applicant’s current knowledge and skills with geriatrics and/or aging research training, its likelihood to enable the applicant’s development into an independent researcher in the aging aspects of his/her clinical specialty, and the adequacy of committed support for protected time and other related expenses.
PDPs should be limited to 5 pages, not including letters of support. Requests for PDP’s will be sent to selected applicants shortly after scientific peer review. It is expected that requested PDPs will be due in May, 2012.
Only the review criteria described below will be considered in the review process. As part of the NIH mission, all applications submitted to the NIH in support of biomedical and behavioral research are evaluated for scientific and technical merit through the NIH peer review system.
For this particular announcement, note the following:
The R03 small grant supports discrete, well-defined projects that realistically can be completed in two years and that require limited levels of funding. Because the research project usually is limited, an R03 grant application may not contain extensive detail or discussion. Accordingly, reviewers should evaluate the conceptual framework and general approach to the problem. Appropriate justification for the proposed work can be provided through literature citations, data from other sources, or from investigator-generated data. Preliminary data are not required, particularly in applications proposing pilot or feasibility studies.
Reviewers will provide an overall impact/priority score to reflect their assessment of the likelihood for the project to exert a sustained, powerful influence on the research field(s) involved, in consideration of the following review criteria and additional review criteria (as applicable for the project proposed).
Reviewers will consider each of the review criteria below in the determination of scientific merit, and give a separate score for each. An application does not need to be strong in all categories to be judged likely to have major scientific impact. For example, a project that by its nature is not innovative may be essential to advance a field.
Significance
Does the project address an important problem or a critical barrier to progress in the field? If the aims of the project are achieved, how will scientific knowledge, technical capability, and/or clinical practice be improved? How will successful completion of the aims change the concepts, methods, technologies, treatments, services, or preventative interventions that drive this field? To what extent does the proposed project introduce aging-related research questions to the applicant’s clinical specialty area? To what extent will the proposed research contribute new and meaningful knowledge in geriatric- or gerontologic science related to the applicant’s clinical specialty?
Investigator(s)
Are the PD/PIs, collaborators, and other researchers well suited to the project? If Early Stage Investigators or New Investigators, or in the early stages of independent careers, do they have appropriate experience and training? If established, have they demonstrated an ongoing record of accomplishments that have advanced their field(s)? If the project is collaborative or multi-PD/PI, do the investigators have complementary and integrated expertise; are their leadership approach, governance and organizational structure appropriate for the project? If established, how will this award assist in the investigator’s transition to aging research and how does the project differ from his/her prior work? To what extent will this award help to bridge the applicant’s clinical specialty with geriatric- or gerontologic research? Does the team of investigators have complementary and integrated expertise in aging and geriatrics appropriate for the project? Is the role of the collaborator(s) appropriate to advance the specific aims of the project and supplement the skills of the PD/PI?
Innovation
Does the application challenge and seek to shift current research or clinical practice paradigms by utilizing novel theoretical concepts, approaches or methodologies, instrumentation, or interventions? Are the concepts, approaches or methodologies, instrumentation, or interventions novel to one field of research or novel in a broad sense? Is a refinement, improvement, or new application of theoretical concepts, approaches or methodologies, instrumentation, or interventions proposed?
Approach
Are the overall strategy, methodology, and analyses
well-reasoned and appropriate to accomplish the specific aims of the project?
Are potential problems, alternative strategies, and benchmarks for success
presented? If the project is in the early stages of development, will the
strategy establish feasibility and will particularly risky aspects be
managed?
If the project involves clinical research, are the plans for 1) protection of
human subjects from research risks, and 2) inclusion of minorities and members
of both sexes/genders, as well as the inclusion of children, justified in terms
of the scientific goals and research strategy proposed?
Environment
Will the scientific environment in which the work will be done contribute to the probability of success? Are the institutional support, equipment and other physical resources available to the investigators adequate for the project proposed? Will the project benefit from unique features of the scientific environment, subject populations, or collaborative arrangements? Does the environment provide sufficient research resources relevant to geriatrics or gerontology and the clinical specialty field of investigation?
As applicable for the project proposed, reviewers will evaluate the following additional items while determining scientific and technical merit, and in providing an overall impact/priority score, but will not give separate scores for these items.
Protections for Human Subjects
For research that involves human subjects but does
not involve one of the six categories of research that are exempt under 45 CFR
Part 46, the committee will evaluate the justification for involvement of human
subjects and the proposed protections from research risk relating to their
participation according to the following five review criteria: 1) risk to
subjects, 2) adequacy of protection against risks, 3) potential benefits to the
subjects and others, 4) importance of the knowledge to be gained, and 5) data
and safety monitoring for clinical trials.
For research that involves human subjects and meets the criteria for one or
more of the six categories of research that are exempt under 45 CFR Part 46,
the committee will evaluate: 1) the justification for the exemption, 2) human
subjects involvement and characteristics, and 3) sources of materials. For
additional information on review of the Human Subjects section, please refer to
the Human
Subjects Protection and Inclusion Guidelines.
Inclusion of Women, Minorities, and Children
When the proposed project involves clinical research, the committee will evaluate the proposed plans for inclusion of minorities and members of both genders, as well as the inclusion of children. For additional information on review of the Inclusion section, please refer to the Human Subjects Protection and Inclusion Guidelines.
Vertebrate Animals
The committee will evaluate the involvement of live vertebrate animals as part of the scientific assessment according to the following five points: 1) proposed use of the animals, and species, strains, ages, sex, and numbers to be used; 2) justifications for the use of animals and for the appropriateness of the species and numbers proposed; 3) adequacy of veterinary care; 4) procedures for limiting discomfort, distress, pain and injury to that which is unavoidable in the conduct of scientifically sound research including the use of analgesic, anesthetic, and tranquilizing drugs and/or comfortable restraining devices; and 5) methods of euthanasia and reason for selection if not consistent with the AVMA Guidelines on Euthanasia. For additional information on review of the Vertebrate Animals section, please refer to the Worksheet for Review of the Vertebrate Animal Section.
Biohazards
Reviewers will assess whether materials or procedures proposed are potentially hazardous to research personnel and/or the environment, and if needed, determine whether adequate protection is proposed.
Resubmissions
For Resubmissions, the committee will evaluate the application as now presented, taking into consideration the responses to comments from the previous scientific review group and changes made to the project.
Renewals
Not applicable.
Revisions
Not applicable.
As applicable for the project proposed, reviewers will consider each of the following items, but will not give scores for these items, and should not consider them in providing an overall impact/priority score.
Applications from Foreign Organizations
Not applicable.
Select Agent Research
Reviewers will assess the information provided in this section of the application, including 1) the Select Agent(s) to be used in the proposed research, 2) the registration status of all entities where Select Agent(s) will be used, 3) the procedures that will be used to monitor possession use and transfer of Select Agent(s), and 4) plans for appropriate biosafety, biocontainment, and security of the Select Agent(s).
Resource Sharing Plans
Reviewers will comment on whether the following Resource Sharing Plans, or the rationale for not sharing the following types of resources, are reasonable: 1) Data Sharing Plan; 2) Sharing Model Organisms; and 3) Genome Wide Association Studies (GWAS).
Budget and Period of Support
Reviewers will consider whether the budget and the requested period of support are fully justified and reasonable in relation to the proposed research.
Applications will be evaluated for scientific and technical
merit by (an) appropriate Scientific Review Group(s) convened by the NIA, in accordance with NIH peer
review policy and procedures, using the stated review
criteria. Review assignments will be shown in the eRA Commons.
As part of the scientific peer review, all applications:
Applications will be assigned to NIA. Applications will compete for available funds with all other recommended applications submitted in response to this FOA. Following initial peer review, recommended applications will receive a second level of review by the National Advisory Council on Aging. The following will be considered in making funding decisions:
After the peer review of the application is completed, the PD/PI will be able to access his or her Summary Statement (written critique) via the eRA Commons.
Information regarding the disposition of applications is available in the NIH Grants Policy Statement.
If the application is under consideration for funding, NIH
will request "just-in-time" information from the applicant as
described in the NIH Grants
Policy Statement.
A formal notification in the form of a Notice of Award (NoA) will be provided
to the applicant organization for successful applications. The NoA signed by
the grants management officer is the authorizing document and will be sent via
email to the grantee’s business official.
Awardees must comply with any funding restrictions described in Section IV.5. Funding Restrictions. Selection
of an application for award is not an authorization to begin performance. Any
costs incurred before receipt of the NoA are at the recipient's risk. These
costs may be reimbursed only to the extent considered allowable pre-award costs.
Any application awarded in response to this FOA will be subject to the DUNS,
CCR Registration, and Transparency Act requirements as noted on the Award
Conditions and Information for NIH Grants website.
All NIH grant and cooperative agreement awards include the NIH Grants Policy Statement as part of the NoA. For these terms of award, see the NIH Grants Policy Statement Part II: Terms and Conditions of NIH Grant Awards, Subpart A: General and Part II: Terms and Conditions of NIH Grant Awards, Subpart B: Terms and Conditions for Specific Types of Grants, Grantees, and Activities. More information is provided at Award Conditions and Information for NIH Grants.
Cooperative Agreement Terms and Conditions of Award
Not Applicable.
When multiple years are involved, awardees will be required to submit the Non-Competing Continuation Grant Progress Report (PHS 2590) annually and financial statements as required in the NIH Grants Policy Statement.
A final progress report, invention statement, and the expenditure data portion of the Federal Financial Report are required for closeout of an award, as described in the NIH Grants Policy Statement.
The Federal Funding Accountability and Transparency Act of 2006 (Transparency Act), includes a requirement for awardees of Federal grants to report information about first-tier subawards and executive compensation under Federal assistance awards issued in FY2011 or later. All awardees of applicable NIH grants and cooperative agreements are required to report to the Federal Subaward Reporting System (FSRS) available at www.fsrs.gov on all subawards over $25,000. See the NIH Grants Policy Statement for additional information on this reporting requirement.
We encourage inquiries concerning this funding opportunity and welcome the opportunity to answer questions from potential applicants.
Grants.gov
Customer Support (Questions regarding Grants.gov registration and
submission, downloading or navigating forms)
Contact Center Phone: 800-518-4726
Email: [email protected]
GrantsInfo (Questions regarding application instructions and
process, finding NIH grant resources)
Telephone 301-710-0267
TTY 301-451-5936
Email: [email protected]
eRA Commons Help Desk(Questions regarding eRA Commons
registration, tracking application status, post submission issues)
Phone: 301-402-7469 or 866-504-9552 (Toll Free)
TTY: 301-451-5939
Email: [email protected]
Susan J. Zieman, MD, PhD
Division of Geriatrics and Clinical Gerontology
National Institute on Aging
7201 Wisconsin Avenue, Suite 3C-307
Bethesda, MD 20892-9205 (for FedEx use 20814)
Phone: 301-496-6761
Fax: 301-402-1784
Email: [email protected]
Ramesh Vemuri, Ph.D.
National Institute on Aging
Phone: (301) 496-9666
Email: [email protected].
Ms. Pamela Adewunmi
National Institute on Aging
Phone: (301) 496-1472
Email: [email protected]
Recently issued trans-NIH policy notices may affect your application submission. A full list of policy notices published by NIH is provided in the NIH Guide for Grants and Contracts. All awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement.
Awards are made under the authorization of Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 45 CFR Parts 74 and 92.
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
|
| ||||||
|
|
|
Department of Health and Human Services (HHS) |
|
|||
|
NIH... Turning Discovery Into Health® |
||||||